11.22.19
6 min. Read

Proteus headcount dip. Smart pill standards.

Issue 029.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a glass-is-more-than-half-full 55 percent open rate. Here's what's happening this week:

  • I spent most of Thursday just outside of Washington DC at a workshop convened by IEEE and US Pharmacopeia focused on thinking through standards for smart pills -- sometimes called digital pills, signaling pills, or as FDA-savvy lawyers call them, ingestible event markers. A few initial thoughts and findings from that below.
  • This slide deck and these presentation notes from Princeton University computer science professor Arvind Narayanan make for a great primer on how to cut through AI hype. It's not healthcare-specific but references some medical use cases. He breaks down AI claims into the genuine, the far from perfect but improving, and the dubious.
  • You probably read this

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
1.26.24
7 min. Read
FDA de novo for Google smartphone thermometer.
1.05.24
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
12.15.23
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
12.01.23
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
11.16.23
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
11.06.23
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
10.27.23
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
10.20.23
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
10.06.23
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
9.29.23
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last